These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1721275)

  • 1. Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy.
    McMichael J; Irish W; McCauley J; Shapiro R; Gordon R; Van Thiel DH; Lieberman R; Warty VS; Fung J; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):2780-2. PubMed ID: 1721275
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of the effects of the drug FK 506 on gingival tissues.
    Adams CK; Famili P
    Transplant Proc; 1991 Dec; 23(6):3193-4. PubMed ID: 1721405
    [No Abstract]   [Full Text] [Related]  

  • 3. Tacrolimus (FK 506) given three times daily after liver transplantation for minimizing nephrotoxicity and neurotoxicity.
    Khalaf H; Al-Asseri A; Bhuiyan J; Nafea O; Al-Sebayel M
    Transplant Proc; 2003 Nov; 35(7):2787-8. PubMed ID: 14612120
    [No Abstract]   [Full Text] [Related]  

  • 4. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early experience with FK 506 induction immunosuppression--suggestion for using oral FK 506.
    Nakazato P; Cox K; Concepcion W; Gish R; Berquist W; Imperial J; Esquivel C
    Transplant Proc; 1991 Dec; 23(6):3019-20. PubMed ID: 1721345
    [No Abstract]   [Full Text] [Related]  

  • 6. FK 506 in solid organ transplantation.
    Fung JJ; Starzl TE
    Transplant Proc; 1994 Oct; 26(5):3017-20. PubMed ID: 7524226
    [No Abstract]   [Full Text] [Related]  

  • 7. Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation.
    Abu-Elmagd KM; Fung J; Draviam R; Shannon W; Jain A; Alessiani M; Takaya S; Venkataramanan R; Warty VS; Tzakis A
    Transplant Proc; 1991 Dec; 23(6):2767-70. PubMed ID: 1721271
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of plasma vs whole blood as matrix for FK 506 drug level monitoring.
    Winkler M; Wonigeit K; Undre N; Ringe B; Oldhafer K; Christians U; Pichlmayr R
    Transplant Proc; 1995 Feb; 27(1):822-5. PubMed ID: 7533433
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro assessment of FK 506 immunosuppressive activity in transplant patients.
    Zeevi A; Venkataramanan R; Warty V; Eiras G; Woan M; Abu-Elmagd K; Alessiani M; Jain A; Demetris AJ; Zerbe T
    Transplant Proc; 1991 Dec; 23(6):2897-9. PubMed ID: 1721307
    [No Abstract]   [Full Text] [Related]  

  • 10. FK 506 versus cyclosporine.
    Starzl TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):511-2. PubMed ID: 7679820
    [No Abstract]   [Full Text] [Related]  

  • 11. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four-year experience with tacrolimus once-daily prolonged release in patients from phase II conversion and de novo kidney, liver, and heart studies.
    van Hooff JP; Alloway RR; Trunečka P; Mourad M
    Clin Transplant; 2011; 25(1):E1-12. PubMed ID: 21158926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].
    Arnold JC; Theilmann L
    Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559
    [No Abstract]   [Full Text] [Related]  

  • 14. Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation.
    Ko S; Nakajima Y; Kanehiro H; Horikawa M; Yoshimura A; Kido K; Taki J; Aomatsu Y; Kin T; Yagura K; Ohyama T; Ohashi K; Yamada T; Nakano H
    Transplant Proc; 1996 Apr; 28(2):1066-8. PubMed ID: 8623229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of FK 506 in liver transplantation.
    Klintmalm GB
    Transplant Proc; 1996 Apr; 28(2):974-6. PubMed ID: 8623484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological disorders in liver and kidney transplant recipients.
    Christe W
    Transplant Proc; 1994 Dec; 26(6):3175-6. PubMed ID: 7527953
    [No Abstract]   [Full Text] [Related]  

  • 17. FK 506 rescue therapy in liver transplantation: outcome and complications.
    McDiarmid SV; Klintmalm G; Busuttil RW
    Transplant Proc; 1991 Dec; 23(6):2996-9. PubMed ID: 1721339
    [No Abstract]   [Full Text] [Related]  

  • 18. Notes on FK 506.
    Starzl TE; Fung J; Todo S; Tzakis A
    Transplant Proc; 1991 Aug; 23(4):2178-9. PubMed ID: 1714647
    [No Abstract]   [Full Text] [Related]  

  • 19. FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients.
    D'Alessandro AM; Kalayoglu M; Pirsch JD; Corwith C; Knechtle SJ; Reed A; Belzer FO
    Transplant Proc; 1991 Dec; 23(6):2987-8. PubMed ID: 1721335
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinicopathological evaluation of kidney transplants in patients given a fixed dose of FK 506. Japanese FK 506 Study Group.
    Transplant Proc; 1991 Dec; 23(6):3111-5. PubMed ID: 1721374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.